Search results

Pulmonary heteroplasia

antiangiogenic therapies ( i.e. daily 40mg tamoxifen plus/minus interferon alpha 3 x 3Mio/week or trofosfamide ...

Infiltrating Duct Carcinoma of Breast – additional opinion

adjuvant hormonotherapy consist of initial treatment by Tamoxifen for 2 years, thereafter switched to an Aromatase Inhibitor. The ... also informs the patient about potential side effects of Tamoxifen treatment, which are not frequent and generally mild. ...

Chronic Atrial Fibrillation in Patient with Prior Hemoptoic Episodes in Bilateral Bronchiectases

due to mammary carcinoma with subsequent radiotherapy and Tamoxifen therapy until May 2005. 72 years old - Hospitalization for ... studies. Medicines : Tamoxifen, beta-blocker, calcium antagonists, acetylsalicylic acid (ASA)., ... oophorectomy, quadrantectomy, radiotherapy, Tamoxifen therapy, beta-blocker, calcium antagonists, antibiotic therapy, ...

Drugs

Actinomycin-D and ifosfamide) Adenexae Adjuvant Tamoxifen Adjuvant chemotherapy Adjuvant treatment with Interferon ... Tachipirina(Paracetamol) Tacrolimus Tamoxifen Tarceva Tauxib Tavor Taxanes Taxol ...

Ovarian Cancer with Metastases

), Gemetabare , Nomafen (20 mg x1), Tamoxifen, Taxol, Gemetabare, Paxol, Caelyx-Oxaliplatin ( Oxilaplatin, ... ), Gemetabare , Nomafen (20 mg x1), Tamoxifen, Taxol, Gemetabare, Paxol, Caelyx-Oxaliplatin ( Oxilaplatin, ...

Infiltrating Duct Carcinoma of Breast

patient should receive at least a 5 year treatment by Tamoxifen switched to aromatase inhibitor . The particulars of this program ... Chemotherapy, hormonal replacement treatment, LHRH-A, Tamoxifen, aromatase inhibitor. Treatments : Lumpectomy, ...

JustAnswer.com